Amgen (AMGN) ended the recent trading session at $314.38, demonstrating a -0.53% swing from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 1.77%.

In the latest trading session, Amgen (AMGN) closed at $318.65, marking a +0.47% move from the previous day. The stock outpaced the S&P 500's daily loss of 1.07%. Elsewhere, the Dow lost 0.62% ...

The appeals court for the Federal Circuit upheld a lower court’s ruling, finding that Regeneron has not sufficiently established that Amgen’s biosimilar Pavblu violates key patents of Eylea. A U.S.

Am­gen has shared ad­di­tion­al Phase 3 da­ta for its rare dis­ease drug Up­liz­na in myas­the­nia gravis, bol­ster­ing the com­pa­ny’s case for la­bel ex­pan­sion be­fore a … ...

Shares of Verizon and Amgen are retreating Wednesday morning, sending the Dow Jones Industrial Average into negative territory. Supported by world-class markets data from Dow Jones and FactSet ...

placebo. Also Read: Amgen Challenges Novo Nordisk’s Ozempic And Eli Lilly’s Zepbound As Its Monthly Weight Loss Drug MariTide Enters Two Late-Stage Trials In addition, IGNITE met the endpoint ...

Hyderabad, Feb 24 (UNI) Amgen India on Monday launched its new technology and innovation center at HITECH city here. The facility spans approximately 524,000 square feet in RMZ Tower 110 of Spire.